Development of Dysplasia in the Pelvic Pouch in Patients With Ulcerative Colitis (UC) and Risk Factors
Primary Purpose
Ulcerative Colitis, Dysplasia, Surgery
Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Endoscopy and biopsy
Sponsored by
About this trial
This is an interventional prevention trial for Ulcerative Colitis focused on measuring Ulcerative colitis, dysplasia, risk factor, surgery
Eligibility Criteria
Inclusion Criteria:
- UC (Ulcerative Colitis)
- IPAA
- risk factor for dysplasia
Exclusion Criteria:
- Not able to give consent
- CD (Crohns disease)
Sites / Locations
- Department of Surgery, Inst for Clinical Sciences, Sahlgrenska University Hospital
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Endoscopy and biopsy
Arm Description
Endoscopy with biopsy taken Endoscopy and biopsy Blood samples Questionnaire
Outcomes
Primary Outcome Measures
Presence of dysplasia in patients with Ulcerative Colitis and Ileal Pouch-Anal Anastomosis
The study ends at above mentioned date. After that, microscopic evaluation, statistics and analysis will be done.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01764542
Brief Title
Development of Dysplasia in the Pelvic Pouch in Patients With Ulcerative Colitis (UC) and Risk Factors
Official Title
Critical Assessment of Routine Surveillance of Asymptomatic Patients With Ulcerative Colitis With Ileal Pouch-anal Anastomosis and Risk Factors for Dysplasia - is There a Rationale?
Study Type
Interventional
2. Study Status
Record Verification Date
April 2016
Overall Recruitment Status
Completed
Study Start Date
February 2010 (undefined)
Primary Completion Date
January 2015 (Actual)
Study Completion Date
February 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Mattias Block
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to study development of dysplasia in the ileal mucosa among patients with Ulcerative Colitis and who previous have hade risk factors for developing cellular changes/dysplasia, i.e. previous dysplasia and/or carcinoma in their specimen.
Detailed Description
Objective Some of the rare complications reported in patients with an ileal pouch-anal anastomosis (IPAA) after colectomy for chronic ulcerative colitis are dysplasia and carcinoma. The supposed pathway is for the ileal pouch mucosa to go through adaptational changes then to progress through the phases of chronic pouchitis, dysplasia and subsequently to adenocarcinoma. The purpose of this study is to study development of dysplasia in the ileal mucosa among patients with Ulcerative Colitis and who previous have hade risk factors for developing cellular changes/dysplasia, i.e. previous dysplasia and/or carcinoma in their specimen.
Methods In a cohort of 680 patients having IPAA with a median follow-up time of 18 years, 75 patients with risk factors for dysplasia were identified. Sixty-five patients were eligible for inclusion, fifty-six patients accepted to participate in the study. Patients are invited for clinical examination, endoscopy with macroscopic evaluation as well as mucosal biopsies. The biopsies are reviewed and evaluated by two independent pathologists, experienced in colonic pathology, concerning morphological changes, dysplasia and potential carcinoma Results Architectural structural changes, inflammation and reactive atypia is noted in the rectal cuff and ileal pouch. So far, none of the biopsies showed genuine dysplasia after a follow up for 18 years (Range 12-23 years). In this respect there is full agreement between the two pathologists.
Further microscopic evaluation are planned for the rest of the participating patients.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ulcerative Colitis, Dysplasia, Surgery
Keywords
Ulcerative colitis, dysplasia, risk factor, surgery
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
56 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Endoscopy and biopsy
Arm Type
Other
Arm Description
Endoscopy with biopsy taken Endoscopy and biopsy Blood samples Questionnaire
Intervention Type
Procedure
Intervention Name(s)
Endoscopy and biopsy
Intervention Description
Endoscopy with biopsy of the ileo-anal pouch and the ileo-anal anastomosis Blood samples
Primary Outcome Measure Information:
Title
Presence of dysplasia in patients with Ulcerative Colitis and Ileal Pouch-Anal Anastomosis
Description
The study ends at above mentioned date. After that, microscopic evaluation, statistics and analysis will be done.
Time Frame
Up to 7 days
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
UC (Ulcerative Colitis)
IPAA
risk factor for dysplasia
Exclusion Criteria:
Not able to give consent
CD (Crohns disease)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lars Börjesson, Surgeon
Organizational Affiliation
Department of Surgery, Sahlgrenska, Göteborg
Official's Role
Study Chair
Facility Information:
Facility Name
Department of Surgery, Inst for Clinical Sciences, Sahlgrenska University Hospital
City
Göteborg
ZIP/Postal Code
41685
Country
Sweden
12. IPD Sharing Statement
Learn more about this trial
Development of Dysplasia in the Pelvic Pouch in Patients With Ulcerative Colitis (UC) and Risk Factors
We'll reach out to this number within 24 hrs